{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T13:06:59Z","timestamp":1795007219454,"version":"4.9.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["FKZ 01GL1730"],"award-info":[{"award-number":["FKZ 01GL1730"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005713","name":"Technische Universit\u00e4t M\u00fcnchen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Depression is one of the leading causes of the global burden of disease, and it has particularly negative consequences for elderly patients. Antidepressants are the most frequently used treatment. We present the first single-group meta-analysis examining: 1) the response rates of elderly patients to antidepressants, and 2) the determinants of antidepressants response in this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched multiple databases for randomized controlled trials on antidepressants in the elderly with major depressive disorder above 65\u2009years (last search: December 2017). Response was defined as 50% improvement on validated rating scales. We extracted response rates from studies and imputed the missing ones with a validated method. Data were pooled in a single-group meta-analysis. Additionally, several potential moderators of response to antidepressants were examined by subgroup and meta-regression analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 44 studies with a total of 6373 participants receiving antidepressants. On average, 50.7% of the patients reached a reduction of at least 50% on the Hamilton Depression Scale (HAMD). Subgroup and meta-regression analyses revealed a better response to treatment for patients in antidepressant-controlled trials compared to placebo-controlled trials. Mean age, study duration, percentage of woman, severity of illness at baseline, dose of antidepressants in fluoxetine equivalents, year of publication, setting (in- or out-patients), antidepressant groups (SSRI, TCA, SSNRI, \u03b12-antagonist, SNRI, MAO-inhibitor), ITT (intention-to-treat) analysis vs completer analysis, sponsorship and overall risk of bias were not significant moderators of response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings suggest an improvement in symptoms can be found in about 50% of the elderly with major depressive disorder treated with antidepressants.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12888-020-02514-2","type":"journal-article","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T10:02:39Z","timestamp":1583316159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["How well do elderly patients with major depressive disorder respond to antidepressants: a systematic review and single-group meta-analysis"],"prefix":"10.1186","volume":"20","author":[{"given":"Katharina","family":"Gutsmiedl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Bighelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Schneider-Thoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Leucht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,4]]},"reference":[{"issue":"10009","key":"2514_CR1","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1016\/S0140-6736(15)61340-X","volume":"386","author":"CJL Murray","year":"2015","unstructured":"Murray CJL, Barber RM, Foreman KJ, Ozgoren AA, Abd-Allah F, Abera SF, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990\u20132013: quantifying the epidemiological transition. Lancet. 2015;386(10009):2145\u201391.","journal-title":"Lancet"},{"issue":"6","key":"2514_CR2","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1001\/archpsyc.57.6.601","volume":"57","author":"D. C. Steffens","year":"2000","unstructured":"Steffens DC, Skoog I, Norton MC, Hart AD, Tschanz JT, Plassman BL et al Prevalence of depression and its treatment in an elderly population: the Cache County study. Arch Gen Psychiatry 2000; 57(6):601\u2013607. Available from: URL: https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/481619\/yoa9308.pdf.","journal-title":"Archives of General Psychiatry"},{"issue":"4","key":"2514_CR3","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.euroneuro.2005.04.012","volume":"15","author":"H-U Wittchen","year":"2005","unstructured":"Wittchen H-U, Jacobi F. Size and burden of mental disorders in Europe--a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol. 2005;15(4):357\u201376.","journal-title":"Eur Neuropsychopharmacol"},{"key":"2514_CR4","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV. 4. ed., 3. print. Washington, DC: American Psychiatric Association; 1994."},{"issue":"2","key":"2514_CR5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1027\/0227-5910\/a000076","volume":"32","author":"S Lapierre","year":"2011","unstructured":"Lapierre S, Erlangsen A, Waern M, de Leo D, Oyama H, Scocco P, et al. A systematic review of elderly suicide prevention programs. Crisis. 2011;32(2):88\u201398.","journal-title":"Crisis"},{"issue":"10128","key":"2514_CR6","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","volume":"391","author":"A Cipriani","year":"2018","unstructured":"Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391(10128):1357\u201366.","journal-title":"Lancet"},{"issue":"2","key":"2514_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/03602530902722679","volume":"41","author":"U Klotz","year":"2009","unstructured":"Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev. 2009;41(2):67\u201376.","journal-title":"Drug Metab Rev"},{"issue":"10","key":"2514_CR8","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1177\/0091270005280297","volume":"45","author":"FE Lotrich","year":"2005","unstructured":"Lotrich FE, Pollock BG. Aging and clinical pharmacology: implications for antidepressants. J Clin Pharmacol. 2005;45(10):1106\u201322.","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"2514_CR9","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1517\/17425255.2015.1021684","volume":"11","author":"J Sultana","year":"2015","unstructured":"Sultana J, Spina E, Trifir\u00f2 G. Antidepressant use in the elderly: the role of pharmacodynamics and pharmacokinetics in drug safety. Expert Opin Drug Metab Toxicol. 2015;11(6):883\u201392.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"3","key":"2514_CR10","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1474-9726.2007.00289.x","volume":"6","author":"DL Dickstein","year":"2007","unstructured":"Dickstein DL, Kabaso D, Rocher AB, Luebke JI, Wearne SL, Hof PR. Changes in the structural complexity of the aged brain. Aging Cell. 2007;6(3):275\u201384.","journal-title":"Aging Cell"},{"issue":"964","key":"2514_CR11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1136\/pgmj.2005.036665","volume":"82","author":"R Peters","year":"2006","unstructured":"Peters R. Ageing and the brain. Postgrad Med J. 2006;82(964):84\u20138.","journal-title":"Postgrad Med J"},{"issue":"3","key":"2514_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0006-3223(94)00174-2","volume":"37","author":"I Hickie","year":"1995","unstructured":"Hickie I, Scott E, Mitchell P, Wilhelm K, Austin M-P, Bennett B. Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry. 1995;37(3):151\u201360.","journal-title":"Biol Psychiatry"},{"issue":"5","key":"2514_CR13","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1046\/j.1532-5415.2002.50206.x","volume":"50","author":"DW Oslin","year":"2002","unstructured":"Oslin DW, Datto CJ, Kallan MJ, Katz IR, Edell WS, TenHave T. Association between medical comorbidity and treatment outcomes in late-life depression. J Am Geriatr Soc. 2002;50(5):823\u20138.","journal-title":"J Am Geriatr Soc"},{"issue":"9","key":"2514_CR14","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.euroneuro.2019.07.130","volume":"29","author":"Marc Krause","year":"2019","unstructured":"Krause M, Gutsmiedl K, Bighelli I, Schneider-Thoma J, Chaimani A, Leucht S. Efficacy and tolerability of pharmacological and non-pharmacological interventions in older patients with major depressive disorder: a systematic review, pairwise and network meta-analysis. Eur Neuropsychopharmacol 2019; 29(9):1003\u20131022. Available from: URL: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0924977X19304237.","journal-title":"European Neuropsychopharmacology"},{"issue":"1","key":"2514_CR15","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1186\/s12888-018-1964-8","volume":"18","author":"I Bighelli","year":"2018","unstructured":"Bighelli I, Huhn M, Schneider-Thoma J, Krause M, Reitmeir C, Wallis S, et al. Response rates in patients with schizophrenia and positive symptoms receiving cognitive behavioural therapy: a systematic review and single-group meta-analysis. BMC Psychiatry. 2018;18(1):380.","journal-title":"BMC Psychiatry"},{"issue":"9","key":"2514_CR16","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.euroneuro.2017.06.011","volume":"27","author":"Y Zhu","year":"2017","unstructured":"Zhu Y, Li C, Huhn M, Rothe P, Krause M, Bighelli I, et al. How well do patients with a first episode of schizophrenia respond to antipsychotics: a systematic review and meta-analysis. Eur Neuropsychopharmacol. 2017;27(9):835\u201344.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"2514_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/00004850-200501000-00010","volume":"20","author":"TA Furukawa","year":"2005","unstructured":"Furukawa TA, Cipriani A, Barbui C, Brambilla P, Watanabe N. Imputing response rates from means and standard deviations in meta-analyses. Int Clin Psychopharmacol. 2005;20(1):49\u201352.","journal-title":"Int Clin Psychopharmacol"},{"issue":"2\u20133","key":"2514_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jad.2012.02.036","volume":"141","author":"RM Kok","year":"2012","unstructured":"Kok RM, Nolen WA, Heeren TJ. Efficacy of treatment in older depressed patients: a systematic review and meta-analysis of double-blind randomized controlled trials with antidepressants. J Affect Disord. 2012;141(2\u20133):103\u201315.","journal-title":"J Affect Disord"},{"issue":"3","key":"2514_CR19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0165-0327(97)00107-9","volume":"46","author":"N Mittmann","year":"1997","unstructured":"Mittmann N, Herrmann N, Einarson TR, Busto UE, Lanct\u00f4t KL, Liu BA, et al. The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis. J Affect Disord. 1997;46(3):191\u2013217.","journal-title":"J Affect Disord"},{"key":"2514_CR20","volume-title":"Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence: DARE (database of reviews of effects)","author":"JC Nelson","year":"2008","unstructured":"Nelson JC. Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence: DARE (database of reviews of effects); 2008."},{"issue":"12","key":"2514_CR21","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.4088\/JCP.10r06531","volume":"72","author":"Enrico Tedeschini","year":"2011","unstructured":"Tedeschini E, Levkovitz Y, Iovieno N, Ameral VE, Nelson JC, Papakostas GI. Efficacy of antidepressants for late-life depression: A meta-analysis and meta-regression of placebo-controlled randomized trials. J Clin psychiatry 2011 [cited 2018 Jul 24]; 72(12):1660\u20131668.","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"11","key":"2514_CR22","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1007\/s00108-007-1945-3","volume":"48","author":"CC Sieber","year":"2007","unstructured":"Sieber CC. Der \u00e4ltere Patient--wer ist das? Internist (Berl). 2007;48(11):1190 1192-4.","journal-title":"Internist (Berl)"},{"issue":"7","key":"2514_CR23","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1176\/appi.ajp.2012.12040474","volume":"170","author":"BR Rutherford","year":"2013","unstructured":"Rutherford BR, Roose SP. A model of placebo response in antidepressant clinical trials. Am J Psychiatry. 2013;170(7):723\u201333.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"2514_CR24","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/ije\/31.1.140","volume":"31","author":"DR Elbourne","year":"2002","unstructured":"Elbourne DR, Altman DG, Higgins JPT, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. Int J Epidemiol. 2002;31(1):140\u20139.","journal-title":"Int J Epidemiol"},{"issue":"6","key":"2514_CR25","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/BF02599201","volume":"7","author":"GW Divine","year":"1992","unstructured":"Divine GW, Brown JT, Frazier LM. The unit of analysis error in studies about physicians' patient care behavior. J Gen Intern Med. 1992;7(6):623\u20139.","journal-title":"J Gen Intern Med"},{"key":"2514_CR26","unstructured":"Higgins JPT ea. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. Chichester, UK: Wiley and Sons; 2011."},{"key":"2514_CR27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1745-6215-10-46","volume":"10","author":"T Wu","year":"2009","unstructured":"Wu T, Li Y, Bian Z, Liu G, Moher D. Randomized trials published in some Chinese journals: how many are randomized? Trials. 2009;10:46.","journal-title":"Trials"},{"key":"2514_CR28","unstructured":"Wu T, Li Y, Liu G. Investigation of authenticity of \u2018claimed\u2019 randomized controlled trials (RCTs) and quality assessment of RCT reports published in China. 14th Cochrane Colloquium; Dublin, UK; Oct 23\u201326, 2006.12."},{"issue":"2","key":"2514_CR29","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3736\/jcim20060204","volume":"4","author":"ZX Bian","year":"2006","unstructured":"Bian ZX, Li YP, Moher D, Dagenais S, Liu L, Wu TX, et al. Improving the quality of randomized controlled trials in Chinese herbal medicine, part I: clinical trial design and methodology. Zhong Xi Yi Jie He Xue Bao. 2006;4(2):120\u20139.","journal-title":"Zhong Xi Yi Jie He Xue Bao"},{"key":"2514_CR30","doi-asserted-by":"publisher","first-page":"i5396","DOI":"10.1136\/bmj.i5396","volume":"355","author":"M Woodhead","year":"2016","unstructured":"Woodhead M. 80% of China's clinical trial data are fraudulent, investigation finds. BMJ. 2016;355:i5396.","journal-title":"BMJ"},{"key":"2514_CR31","doi-asserted-by":"publisher","first-page":"j2970","DOI":"10.1136\/bmj.j2970","volume":"357","author":"J Parry","year":"2017","unstructured":"Parry J. China vows to clamp down on academic fraud amid medical journal scandal. BMJ. 2017;357:j2970.","journal-title":"BMJ"},{"issue":"1","key":"2514_CR32","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12874-018-0554-2","volume":"18","author":"Z Tong","year":"2018","unstructured":"Tong Z, Li F, Ogawa Y, Watanabe N, Furukawa TA. Quality of randomized controlled trials of new generation antidepressants and antipsychotics identified in the China National Knowledge Infrastructure (CNKI): a literature and telephone interview study. BMC Med Res Methodol. 2018;18(1):96.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"2514_CR33","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56\u201362.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2514_CR34","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382\u20139.","journal-title":"Br J Psychiatry"},{"issue":"2\u20133","key":"2514_CR35","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jad.2012.12.001","volume":"148","author":"S Leucht","year":"2013","unstructured":"Leucht S, Fennema H, Engel R, Kaspers-Janssen M, Lepping P, Szegedi A. What does the HAMD mean? J Affect Disord. 2013;148(2\u20133):243\u20138.","journal-title":"J Affect Disord"},{"key":"2514_CR36","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jad.2016.12.041","volume":"210","author":"S Leucht","year":"2017","unstructured":"Leucht S, Fennema H, Engel RR, Kaspers-Janssen M, Lepping P, Szegedi A. What does the MADRS mean? Equipercentile linking with the CGI using a company database of mirtazapine studies. J Affect Disord. 2017;210:287\u201393.","journal-title":"J Affect Disord"},{"key":"2514_CR37","doi-asserted-by":"crossref","unstructured":"Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to meta-analysis. Chichester, UK: John Wiley & Sons, Ltd; 2009.","DOI":"10.1002\/9780470743386"},{"issue":"7414","key":"2514_CR38","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ"},{"key":"2514_CR39","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jad.2015.03.021","volume":"180","author":"Y Hayasaka","year":"2015","unstructured":"Hayasaka Y, Purgato M, Magni LR, Ogawa Y, Takeshima N, Cipriani A, et al. Dose equivalents of antidepressants: evidence-based recommendations from randomized controlled trials. J Affect Disord. 2015;180:179\u201384.","journal-title":"J Affect Disord"},{"key":"2514_CR40","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jad.2017.09.042","volume":"226","author":"S Leucht","year":"2018","unstructured":"Leucht S, Fennema H, Engel RR, Kaspers-Janssen M, Szegedi A. Translating the HAM-D into the MADRS and vice versa with equipercentile linking. J Affect Disord. 2018;226:326\u201331.","journal-title":"J Affect Disord"},{"issue":"5","key":"2514_CR41","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1177\/0269881116642903","volume":"30","author":"DJ Nutt","year":"2016","unstructured":"Nutt DJ, Blier P. Neuroscience-based Nomenclature (NbN) for Journal of Psychopharmacology. J Psychopharmacol (Oxford, England). 2016;30(5):413\u20135.","journal-title":"J Psychopharmacol (Oxford, England)"},{"key":"2514_CR42","doi-asserted-by":"publisher","DOI":"10.1055\/b-003-129299","volume-title":"Pharmakologie und Toxikologie","author":"KH Graefe","year":"2016","unstructured":"Graefe KH, Lutz W, B\u00f6nisch H. Pharmakologie und Toxikologie. Stuttgart: Georg Thieme Verlag; 2016."},{"key":"2514_CR43","unstructured":"Fisher LD, Dixon DO, Herson J, Frankowski RK, Hearron MS, Peace KE, editors. Intention to Treat in Clinical Trials \/\/ Statistical issues in drug research and development. New York: Dekker; 1990. (Statistics, textbooks and monographs; vol 106)."},{"issue":"7","key":"2514_CR44","doi-asserted-by":"publisher","first-page":"e010919","DOI":"10.1136\/bmjopen-2015-010919","volume":"6","author":"TA Furukawa","year":"2016","unstructured":"Furukawa TA, Salanti G, Atkinson LZ, Leucht S, Ruhe HG, Turner EH, et al. Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis. BMJ Open. 2016;6(7):e010919.","journal-title":"BMJ Open"},{"issue":"6","key":"2514_CR45","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1017\/S0924933800000705","volume":"8","author":"JP Bocksberger","year":"1993","unstructured":"Bocksberger JP, Gachoud JP, Richard J, Dick P. Comparison of the efficacy of moclobemide and fluvoxamine in elderly patients with a severe depressive episode. Eur Psychiatry. 1993;8(6):319\u201324.","journal-title":"Eur Psychiatry"},{"key":"2514_CR46","unstructured":"EUCTR-001829-33-FR. Duloxetine Versus Placebo in the Long-Term Treatment of Patients with Late-Life Major Depression - HMFA: https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/search?query=eudract_number:2008-001829-33; 2008."},{"issue":"6","key":"2514_CR47","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/j.1600-0447.1991.tb05579.x","volume":"83","author":"AL Phanjoo","year":"1991","unstructured":"Phanjoo AL, Wonnacott S, Hodgson A. Double-blind comparative multicentre study of fluvoxamine and mianserin in the treatment of major depressive episode in elderly people. Acta Psychiatr Scand. 1991;83(6):476\u20139.","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"2514_CR48","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1742-1241.1991.tb08868.x","volume":"45","author":"MK Rahman","year":"1991","unstructured":"Rahman MK, Akhtar MJ, Savla NC, Sharma RR, Kellett JM, Ashford JJ. A double-blind, randomised comparison of fluvoxamine with dothiepin in the treatment of depression in elderly patients. Br J Clin Pract. 1991;45(4):255\u20138.","journal-title":"Br J Clin Pract"},{"issue":"1","key":"2514_CR49","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jagp.2013.01.019","volume":"22","author":"M Robinson","year":"2014","unstructured":"Robinson M, Oakes TM, Raskin J, Liu P, Shoemaker S, Nelson JC. Acute and long-term treatment of late-life major depressive disorder: duloxetine versus placebo. Am J Geriatr Psychiatr. 2014;22(1):34\u201345.","journal-title":"Am J Geriatr Psychiatr"},{"issue":"7109","key":"2514_CR50","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334.","journal-title":"BMJ"},{"issue":"10","key":"2514_CR51","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1093\/gerona\/glx162","volume":"73","author":"PJ Brown","year":"2018","unstructured":"Brown PJ, Wall MM, Chen C, Levine ME, Yaffe K, Roose SP, et al. Biological age, not chronological age, is associated with late-life depression. J Gerontol A Biol Sci Med Sci. 2018;73(10):1370\u20136.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"2514_CR52","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1176\/appi.ajp.2007.07050744","volume":"165","author":"GS Alexopoulos","year":"2008","unstructured":"Alexopoulos GS, Murphy CF, Gunning-Dixon FM, Latoussakis V, Kanellopoulos D, Klimstra S, et al. Microstructural white matter abnormalities and remission of geriatric depression. Am J Psychiatry. 2008;165(2):238\u201344.","journal-title":"Am J Psychiatry"},{"key":"2514_CR53","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1192\/bjp.188.2.180","volume":"188","author":"DV Iosifescu","year":"2006","unstructured":"Iosifescu DV, Renshaw PF, Lyoo IK, Lee HK, Perlis RH, Papakostas GI, et al. Brain white-matter hyperintensities and treatment outcome in major depressive disorder. Br J Psychiatry. 2006;188:180\u20135.","journal-title":"Br J Psychiatry"},{"issue":"4","key":"2514_CR54","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1037\/0882-7974.11.4.572","volume":"11","author":"AM Zeiss","year":"1996","unstructured":"Zeiss AM, Lewinsohn PM, Rohde P, Seeley JR. Relationship of physical disease and functional impairment to depression in older people. Psychol Aging. 1996;11(4):572\u201381.","journal-title":"Psychol Aging"},{"issue":"1\u20133","key":"2514_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2012.11.053","volume":"147","author":"R Calati","year":"2013","unstructured":"Calati R, Salvina Signorelli M, Balestri M, Marsano A, de Ronchi D, Aguglia E, et al. Antidepressants in elderly: metaregression of double-blind, randomized clinical trials. J Affect Disord. 2013;147(1\u20133):1\u20138.","journal-title":"J Affect Disord"},{"issue":"5","key":"2514_CR56","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.jpsychires.2008.07.002","volume":"43","author":"EA Young","year":"2009","unstructured":"Young EA, Kornstein SG, Marcus SM, Harvey AT, Warden D, Wisniewski SR, et al. Sex differences in response to citalopram: a STAR*D report. J Psychiatr Res. 2009;43(5):503\u201311.","journal-title":"J Psychiatr Res"},{"issue":"1","key":"2514_CR57","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/JGP.0b013e3181256b1d","volume":"16","author":"JR Sneed","year":"2008","unstructured":"Sneed JR, Rutherford BR, Rindskopf D, Lane DT, Sackeim HA, Roose SP. Design makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depression. Am J Geriatr Psychiatr. 2008;16(1):65\u201373.","journal-title":"Am J Geriatr Psychiatr"},{"issue":"1\u20132","key":"2514_CR58","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1300\/J018v05n01_09","volume":"5","author":"JA Yesavage","year":"1986","unstructured":"Yesavage JA, Sheikh JI. 9\/geriatric depression scale (GDS). Clin Gerontol. 1986;5(1\u20132):165\u201373.","journal-title":"Clin Gerontol"},{"issue":"7","key":"2514_CR59","first-page":"28","volume":"4","author":"J Busner","year":"2007","unstructured":"Busner J, Targum SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont). 2007;4(7):28\u201337.","journal-title":"Psychiatry (Edgmont)"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-020-02514-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12888-020-02514-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-020-02514-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T23:00:51Z","timestamp":1695855651000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-020-02514-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,4]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2514"],"URL":"https:\/\/doi.org\/10.1186\/s12888-020-02514-2","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,4]]},"assertion":[{"value":"31 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SL has received honoraria for consulting from LB Pharma International B.V., H. Lundbeck A\/S, Otsuka Pharmaceutical Co., Ltd., Teva Pharmaceutical Industries Limited, Chemical Works of Gedeon Richter Plc., Recordati S.p.A., LTS Lohmann Therapie-Systeme AG, Boehringer Ingelheim International GmbH; and for lectures from Janssen Global Services, LLC, Eli Lilly and Company, H. Lundbeck A\/S, Otsuka Pharmaceutical Co., Ltd.Sanofi-aventis Groupe and Les Laboratoires Servier. All other authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"102"}}